Choksi Laborator

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE493D01013
  • NSEID:
  • BSEID: 526546
INR
128.00
3 (2.4%)
BSENSE

Jun 18

BSE+NSE Vol: 757

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 525405,
    "name": "Choksi Laborator",
    "stock_name": "Choksi Laborator",
    "full_name": "Choksi Laboratories Ltd",
    "name_url": "stocks-analysis/choksi-laborator",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "128.00",
    "chg": 3,
    "chgp": "2.4%",
    "dir": 1,
    "prev_price": "125.00",
    "mcapval": "83.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526546,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE493D01013",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "757 ",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/choksi-laborator-525405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-flat-financials-4002206",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ChoksiLaborator_mojoScore_4002206.png",
        "date": "2026-05-21 08:03:47",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 May 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain subdued. The stock’s recent price surge of 12.42% and improved technical signals contrast with flat quarterly financials and weak long-term fundamentals, presenting a complex picture for investors."
      },
      {
        "title": "When is the next results date for Choksi Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-choksi-laboratories-ltd-3999631",
        "imagepath": "",
        "date": "2026-05-19 23:17:08",
        "description": "Choksi Laboratories Ltd is scheduled to declare its results on 25 May 2026...."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-3963000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3963000.png",
        "date": "2026-04-26 10:10:34",
        "description": "Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvement-and-valuation-appeal-3945143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3945143.png",
        "date": "2026-04-14 08:07:19",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook, even as its fundamental and financial metrics remain under pressure. The revised rating highlights a mild improvement in technical indicators, balanced against persistent challenges in valuation and financial trends."
      },
      {
        "title": "Choksi Laboratories Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3936456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3936456.png",
        "date": "2026-04-08 08:03:13",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating as of 7 April 2026. The downgrade reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, signalling caution for investors amid challenging market conditions."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-flat-financials-3929568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3929568.png",
        "date": "2026-04-02 08:03:11",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing fundamental challenges, signalling a cautious but slightly more optimistic stance from analysts."
      },
      {
        "title": "Choksi Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3923432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3923432.png",
        "date": "2026-03-30 08:02:02",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 27 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and ongoing valuation concerns, signalling heightened risks for investors amid a challenging market environment."
      }
    ],
    "total": 13,
    "sid": "525405",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/choksi-laboratories-525405"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "26-May-2026",
      "details": "Submission of newspaper publication of financial result for the period ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Meeting Of Board Of Directors Held On 25.05.2026",
      "datetime": "25-May-2026",
      "details": "1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March 2026 along with the along with the Auditors Report thereon Statement of Assets and Liabilities and Cash Flow Statement; 2. Considered and approved the Annual Secretarial Compliance Report for the year ended 31st March 2025 as required under Regulation 24A of SEBI (LODR) 2015; 3. Other routine businesses with the permission of chair.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "25-May-2026",
      "details": "Submission of Annual Secretarial Compliance report under Regulation 24A issued by M/s Surabhi Agrawal & Associate for the year ended 31.03.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

26-May-2026 | Source : BSE

Submission of newspaper publication of financial result for the period ended 31.03.2026

Board Meeting Outcome for Meeting Of Board Of Directors Held On 25.05.2026

25-May-2026 | Source : BSE

1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March 2026 along with the along with the Auditors Report thereon Statement of Assets and Liabilities and Cash Flow Statement; 2. Considered and approved the Annual Secretarial Compliance Report for the year ended 31st March 2025 as required under Regulation 24A of SEBI (LODR) 2015; 3. Other routine businesses with the permission of chair.

Compliances-Reg.24(A)-Annual Secretarial Compliance

25-May-2026 | Source : BSE

Submission of Annual Secretarial Compliance report under Regulation 24A issued by M/s Surabhi Agrawal & Associate for the year ended 31.03.2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available